Physiology and pathophysiology of matrix metalloproteases
Top Cited Papers
Open Access
- 18 July 2010
- journal article
- review article
- Published by Springer Science and Business Media LLC in Amino Acids
- Vol. 41 (2), 271-290
- https://doi.org/10.1007/s00726-010-0689-x
Abstract
Matrix metalloproteases (MMPs) comprise a family of enzymes that cleave protein substrates based on a conserved mechanism involving activation of an active site-bound water molecule by a Zn^2+ ion. Although the catalytic domain of MMPs is structurally highly similar, there are many differences with respect to substrate specificity, cellular and tissue localization, membrane binding and regulation that make this a very versatile family of enzymes with a multitude of physiological functions, many of which are still not fully understood. Essentially, all members of the MMP family have been linked to disease development, notably to cancer metastasis, chronic inflammation and the ensuing tissue damage as well as to neurological disorders. This has stimulated a flurry of studies into MMP inhibitors as therapeutic agents, as well as into measuring MMP levels as diagnostic or prognostic markers. As with most protein families, deciphering the function(s) of MMPs is difficult, as they can modify many proteins. Which of these reactions are physiologically or pathophysiologically relevant is often not clear, although studies on knockout animals, human genetic and epigenetic, as well as biochemical studies using natural or synthetic inhibitors have provided insight to a great extent. In this review, we will give an overview of 23 members of the human MMP family and describe functions, linkages to disease and structural and mechanistic features. MMPs can be grouped into soluble (including matrilysins) and membrane-anchored species. We adhere to the ‘MMP nomenclature’ and provide the reader with reference to the many, often diverse, names for this enzyme family in the introduction.Keywords
This publication has 160 references indexed in Scilit:
- Active MMP‐2 effectively identifies the presence of colorectal cancerInternational Journal of Cancer, 2009
- Biochemical evidence of the interactions of membrane type-1 matrix metalloproteinase (MT1-MMP) with adenine nucleotide translocator (ANT): potential implications linking proteolysis with energy metabolism in cancer cellsBiochemical Journal, 2009
- MMP-1 serum levels predict coronary atherosclerosis in humansCardiovascular Diabetology, 2009
- The hemopexin domain of MMP‐9 inhibits angiogenesis and retards the growth of intracranial glioblastoma xenograft in nude miceInternational Journal of Cancer, 2008
- Membrane type 1-matrix metalloproteinase: Substrate diversity in pericellular proteolysisSeminars in Cell & Developmental Biology, 2008
- Collagenase-2 (matrix metalloproteinase-8) plays a protective role in tongue cancerBritish Journal of Cancer, 2008
- Control of matrix metalloproteinase catalytic activityMatrix Biology, 2007
- Membrane type matrix metalloproteinases (MMPs) show differential expression in non-small cell lung cancer (NSCLC) compared to normal lung: Correlation of MMP-14 mRNA expression and proteolytic activityEuropean Journal of Cancer, 2007
- Matrix metalloproteinase-7 degrades all insulin-like growth factor binding proteins and facilitates insulin-like growth factor bioavailabilityBiochemical and Biophysical Research Communications, 2005
- ADAM28 is activated by MMP-7 (matrilysin-1) and cleaves insulin-like growth factor binding protein-3Biochemical and Biophysical Research Communications, 2004